194 related articles for article (PubMed ID: 36672495)
1. DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway.
Jiang M; Song Y; Liu H; Jin Y; Li R; Zhu X
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672495
[TBL] [Abstract][Full Text] [Related]
2. Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition.
Amos A; Jiang N; Zong D; Gu J; Zhou J; Yin L; He X; Xu Y; Wu L
BMC Cancer; 2023 Feb; 23(1):117. PubMed ID: 36737723
[TBL] [Abstract][Full Text] [Related]
3. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.
Mao C; Liu X; Zhang Y; Lei G; Yan Y; Lee H; Koppula P; Wu S; Zhuang L; Fang B; Poyurovsky MV; Olszewski K; Gan B
Nature; 2021 May; 593(7860):586-590. PubMed ID: 33981038
[TBL] [Abstract][Full Text] [Related]
4. A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression.
Hai Y; Fan R; Zhao T; Lin R; Zhuang J; Deng A; Meng S; Hou Z; Wei G
Pharmacol Res; 2024 Apr; 202():107115. PubMed ID: 38423231
[TBL] [Abstract][Full Text] [Related]
5. Dihydroorotate dehydrogenase regulates ferroptosis in neurons after spinal cord injury via the P53-ALOX15 signaling pathway.
Li D; Lu X; Xu G; Liu S; Gong Z; Lu F; Xia X; Jiang J; Wang H; Zou F; Ma X
CNS Neurosci Ther; 2023 Jul; 29(7):1923-1939. PubMed ID: 36942513
[TBL] [Abstract][Full Text] [Related]
6. Manganese induces tumor cell ferroptosis through type-I IFN dependent inhibition of mitochondrial dihydroorotate dehydrogenase.
Zhang S; Kang L; Dai X; Chen J; Chen Z; Wang M; Jiang H; Wang X; Bu S; Liu X; Zhang G; Tang H
Free Radic Biol Med; 2022 Nov; 193(Pt 1):202-212. PubMed ID: 36228830
[TBL] [Abstract][Full Text] [Related]
7. Cloning and Characterization of Yak
Xu H; Li Y; Li Q; Ma Z; Yin S; He H; Xiong Y; Xiong X; Lan D; Li J; Fu W
Animals (Basel); 2023 Dec; 13(24):. PubMed ID: 38136869
[TBL] [Abstract][Full Text] [Related]
8. Dihydroorotate dehydrogenase promotes cell proliferation and suppresses cell death in esophageal squamous cell carcinoma and colorectal carcinoma.
Shi ZZ; Jin X; Li WT; Tao H; Song SJ; Fan ZW; Jiang W; Liang JW; Bai J
Transl Cancer Res; 2023 Sep; 12(9):2294-2307. PubMed ID: 37859742
[TBL] [Abstract][Full Text] [Related]
9. Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy.
Yao L; Yang N; Zhou W; Akhtar MH; Zhou W; Liu C; Song S; Li Y; Han W; Yu C
Adv Healthc Mater; 2023 Oct; 12(26):e2300871. PubMed ID: 37204046
[TBL] [Abstract][Full Text] [Related]
10. Dihydroorotate dehydrogenase Inhibitors Target c-Myc and Arrest Melanoma, Myeloma and Lymphoma cells at S-phase.
Dorasamy MS; Choudhary B; Nellore K; Subramanya H; Wong PF
J Cancer; 2017; 8(15):3086-3098. PubMed ID: 28928900
[TBL] [Abstract][Full Text] [Related]
11. 17β-oestradiol inhibits ferroptosis in the hippocampus by upregulating DHODH and further improves memory decline after ovariectomy.
Tian Y; Xie Y; Guo Z; Feng P; You Y; Yu Q
Redox Biol; 2023 Jun; 62():102708. PubMed ID: 37116254
[TBL] [Abstract][Full Text] [Related]
12. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo.
Cheng Q; Bao L; Li M; Chang K; Yi X
J Obstet Gynaecol Res; 2021 Jul; 47(7):2481-2491. PubMed ID: 33882617
[TBL] [Abstract][Full Text] [Related]
13. POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase.
Peng Y; Zheng W; Chen Y; Lei X; Yang Z; Yang Y; Liang W; Sun K; Li G; Yu J
Cell Death Dis; 2024 Apr; 15(4):248. PubMed ID: 38575587
[TBL] [Abstract][Full Text] [Related]
14. The Warburg effect modulates DHODH role in ferroptosis: a review.
Amos A; Amos A; Wu L; Xia H
Cell Commun Signal; 2023 May; 21(1):100. PubMed ID: 37147673
[TBL] [Abstract][Full Text] [Related]
15. Dihydroorotate Dehydrogenase Inhibitors Promote Cell Cycle Arrest and Disrupt Mitochondria Bioenergetics in Ramos Cells.
Kadir MFA; Othman S; Nellore K
Curr Pharm Biotechnol; 2020; 21(15):1654-1665. PubMed ID: 32525770
[TBL] [Abstract][Full Text] [Related]
16. d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy.
Li J; Yuan J; Li Y; Wang J; Xie Q; Ma R; Wang J; Ren M; Lu D; Xu Z
Phytomedicine; 2022 Nov; 106():154411. PubMed ID: 36030746
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition.
Madak JT; Cuthbertson CR; Chen W; Showalter HD; Neamati N
Chemistry; 2017 Oct; 23(56):13875-13878. PubMed ID: 28833638
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Functional Nanomedicine Enhances Ferroptosis Therapy for Breast Tumors by a Blocking Defensive Redox System.
Chen S; Yang J; Liang Z; Li Z; Xiong W; Fan Q; Shen Z; Liu J; Xu Y
ACS Appl Mater Interfaces; 2023 Jan; 15(2):2705-2713. PubMed ID: 36622364
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
